SMOKING CESSATION IS AN increasingly important area of focus for pharmaceutical companies, healthcare entities and governments. There are 1.4 billion smokers in the world, and smoking is a known cause of heart disease, lung cancer, respiratory infections and many other diseases. This has created a large market for smoking cessation aids. The market, which Zyban currently holds a tenuous lock on, is about to change, with a major new brand ready to shake up the current market share. At the same time, the high incidence of smoking and strong public-sector motivation to reduce smoking signals room for new entrants. The market for treatments for alcohol and drug abuse, now dominated by Subutex and Campral, will also see growth and a robust line of new products. Kalorama's Smoking Cessation and Addiction Treatments: A World Market Analysis covers the market for pharmaceuticals that assist with smoking cessation and addiction treatment. Using information gathered for Kalorama's larger report on Psychotherapeutics: the World Market and interviews with psychotherapeutic industry insiders therein, this report takes a more detailed look at the combined market for both smoking cessation and alcohol/drug addiction treatments. The report includes:
Product managers, business development executives, marketing managers, as well as executives in financial and advertising companies, are among those who will find this report a useful resource. Related Reports: Drug Delivery Markets: Oral DeliveryJul 1, 2009 - KLI2290102 - $2,995.00 Advances in Ophthalmology: Markets in the Treatment of Eye Disorders and Corrective Vision, 2nd Ediiton Jun 1, 2009 - KLI2271479 - $3,500.00 Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Jun 1, 2009 - KLI2155319 - $3,995.00 H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays) May 1, 2009 - KLI2241990 - $800.00 The World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition May 1, 2009 - KLI2218043 - $3,995.00 Rx to OTC Switches 2009 May 1, 2009 - KLI2196300 - $3,500.00 Worldwide Wound Care: Total Market Coverage (Vols. I-III: Skin Ulcers, Burns, Surgical and Trauma Wounds), 4th Edition May 1, 2009 - KLI2123150 - $4,995.00 Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition May 1, 2009 - KLI2091313 - $3,995.00 World Veterinary Health Products (Animal Pharmaceuticals, Vaccines, OTC and Performance Enhancers) May 1, 2009 - KLI1829596 - $3,500.00 Healthcare in a Recession (OTC, Generics, Out of Pocket Spending, Healthcare Legislation, Retail Clinics, Outsourcing and Other Topics) Apr 1, 2009 - KLI2123096 - $1,995.00 |
800.298.5603
Int'l: +1.240.747.3096
Questions?
Contact a research specialist >
Most Popular Research
Outsourcing in Drug Discovery: The Contract Research (CRO) Market, 3rd Edition
Clinical Nutrition Products: World Market, 2nd. Edition
Clinical Nutrition Products: World Markets, 3rd Edition
Vaccines: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
The Return of the Rx to OTC Switch: Market Analysis and Product Management Strategies
Prescription Dermatological Drugs: Worldwide Market, 6th Edition
|
|||||||||
|
Privacy Policy
|
Terms and Conditions
|
Site Map
|
Return Policy
|
Press
|
Help FAQs
|